Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Community Health Systems
CYH
$385M
| $8.11M | ﹤0.01% |
2,759,204
-275,884
| -9% | -$894K |
|
2202
Myriad Genetics
MYGN
$530M
| $8.11M | ﹤0.01% |
1,801,478
+47,767
| +3% | +$249K |
|
2203
Taysha Gene Therapies
TSHA
$1.59B
| $8.08M | ﹤0.01% |
1,808,599
-94,379
| -5% | -$439K |
|
2204
Univest Financial
UVSP
$1.23B
| $8.01M | ﹤0.01% |
233,694
-1,279
| -0.5% | -$43.3K |
|
2205
Coursera
COUR
$1.54B
| $7.99M | ﹤0.01% |
1,373,641
-18,479
| -1% | -$115K |
|
2206
Amerant Bancorp
AMTB
$1.12B
| $7.96M | ﹤0.01% |
361,363
+15,793
| +5% | +$339K |
|
2207
Biohaven
BHVN
$2.16B
| $7.96M | ﹤0.01% |
941,077
+93,665
| +11% | +$1.02M |
|
|
BKV
2208
BKV Corp
BKV
$2.79B
| $7.94M | ﹤0.01% |
278,572
+78,773
| +39% | +$2.28M |
|
2209
Covenant Logistics
CVLG
$1.18B
| $7.92M | ﹤0.01% |
291,673
-7,857
| -3% | -$211K |
|
2210
Xeris Biopharma Holdings
XERS
$1.44B
| $7.89M | ﹤0.01% |
1,359,657
-44,167
| -3% | -$293K |
|
2211
ARKO Corp
ARKO
$890M
| $7.86M | ﹤0.01% |
1,413,355
-35,403
| -2% | -$197K |
|
2212
Adtran
ADTN
$798M
| $7.85M | ﹤0.01% |
624,112
-62,828
| -9% | -$637K |
|
2213
First Advantage
FA
$3.37B
| $7.85M | ﹤0.01% |
667,597
-4,781
| -0.7% | -$58.5K |
|
2214
Paymentus
PAY
$3.63B
| $7.81M | ﹤0.01% |
307,422
+10,113
| +3% | +$266K |
|
2215
Sharplink Inc
SBET
$1.22B
| $7.73M | ﹤0.01% |
1,199,220
+37,674
| +3% | +$305K |
|
2216
Tootsie Roll Industries
TR
$2.82B
| $7.72M | ﹤0.01% |
180,727
-2,615
| -1% | -$102K |
|
2217
Community Trust Bancorp
CTBI
$1.38B
| $7.7M | ﹤0.01% |
126,839
-2,219
| -2% | -$135K |
|
2218
BioLife Solutions
BLFS
$1.46B
| $7.7M | ﹤0.01% |
403,485
+23,744
| +6% | +$525K |
|
2219
Oric Pharmaceuticals
ORIC
$1.25B
| $7.67M | ﹤0.01% |
605,037
-16,049
| -3% | -$182K |
|
2220
STAAR Surgical
STAA
$1.16B
| $7.64M | ﹤0.01% |
408,576
-72,028
| -15% | -$1.37M |
|
2221
Tyra Biosciences
TYRA
$1.82B
| $7.63M | ﹤0.01% |
199,111
-315
| -0.2% | -$10.2K |
|
2222
The RealReal
REAL
$1.34B
| $7.6M | ﹤0.01% |
836,608
+12,130
| +1% | +$153K |
|
2223
BRC Group Holdings
RILY
$277M
| $7.57M | ﹤0.01% |
1,034,344
-88,835
| -8% | -$663K |
|
2224
Fluence Energy
FLNC
$1.78B
| $7.55M | ﹤0.01% |
548,522
+17,670
| +3% | +$354K |
|
2225
United Fire Group
UFCS
$1.32B
| $7.54M | ﹤0.01% |
203,450
+1,647
| +0.8% | +$60.8K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.